By forming a complex with ARF1, IQGAP1 activates the ERK signaling pathway, which enhances tumor cell invasiveness and confers resistance to BRAFV600E inhibitors, such as vemurafenib. This evidence concerns the gene IQGAP1 and neoplasm.